Etienne Caron, PhD

Dr. Caron is a Canadian scientist with a background in Biotechnology and Systems Immunology. He received his PhD from the University of Montreal and completed his education at ETH-Zürich in Switzerland under the guidance of Dr. Ruedi Aebersold. Dr. Caron is known for his international leadership and expertise in immunopeptidomics for the global analysis of MHC-associated peptides using mass spectrometry technologies. His scientific program has the potential to revolutionize the research on vaccine development, cancer immunotherapy, and treatment of neurodegenerative diseases and aging.

Dr. Caron was recruited in 2023 by the Yale Center for Immuno-Oncology (YCIO) and the Department of Immunobiology. He is also a member of the Yale Center for Infection and Immunity (CII), and the Yale Center for Systems and Engineering Immunology (CSEI).

Dr. Caron is co-founder and former chair (2015-2020) of the Human Immunopeptidome Project. He also co-founded the start-up Neomabs Biotechnologies Inc., with the goal of transforming the treatment of childhood leukemia through targeted immunotherapies. Dr. Caron has also provided distinctive services to the life sciences industry through numerous collaborations with companies such as Biognosys, ImmunXperts, CellCarta, Genentech, and Flagship Pioneering.